81 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 2

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
M6PRMannose-6-phosphate receptor (cation dependent)FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
MPLMPL proto-oncogene, thrombopoietin receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Not detected
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
MS4A2Membrane-spanning 4-domains, subfamily A, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Mixed
OXTROxytocin receptorFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
PDGFRBPlatelet-derived growth factor receptor, beta polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
PGFPlacental growth factorCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PLATPlasminogen activator, tissueCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Mixed
PLAUPlasminogen activator, urokinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
PLAURPlasminogen activator, urokinase receptorCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PLIN3Perilipin 3FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
PTH2RParathyroid hormone 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
RAMP1Receptor (G protein-coupled) activity modifying protein 1FDA approved drug targets
Predicted membrane proteins
Mixed
SCTRSecretin receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Group enriched
SERPINB2Serpin peptidase inhibitor, clade B (ovalbumin), member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
SERPINC1Serpin peptidase inhibitor, clade C (antithrombin), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPIND1Serpin peptidase inhibitor, clade D (heparin cofactor), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPINE1Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
SNAP25Synaptosomal-associated protein, 25kDaFDA approved drug targets
Predicted intracellular proteins
Transporters
Tissue enriched
SYT2Synaptotagmin IIFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
TNFRSF8Tumor necrosis factor receptor superfamily, member 8Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
TNFSF11Tumor necrosis factor (ligand) superfamily, member 11Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
TNFSF13BTumor necrosis factor (ligand) superfamily, member 13bCancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
TSHRThyroid stimulating hormone receptorCancer-related genes
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
VAMP1Vesicle-associated membrane protein 1 (synaptobrevin 1)FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Transporters
Expressed in all
VEGFAVascular endothelial growth factor ACancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
VEGFBVascular endothelial growth factor BCancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
VWFVon Willebrand factorCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Mixed

« prev | Page of 2